
1. Br J Haematol. 2018 Nov;183(3):512-516. doi: 10.1111/bjh.14991. Epub 2017 Oct 26.

Leukaemic stem cell load at diagnosis predicts the development of relapse in
young acute myeloid leukaemia patients.

Hanekamp D(1), Denys B(2), Kaspers GJL(3)(4), Te Marvelde JG(5), Schuurhuis
GJ(1), De Haas V(6), De Moerloose B(7)(8), de Bont ES(9), Zwaan CM(10), de Jong
A(6), Depreter B(7)(8)(11), Lammens T(7)(8), Philippé J(2)(8)(11), Cloos J(1)(3),
van der Velden VHJ(5).

Author information: 
(1)Department of Haematology, VU University Medical Center, Amsterdam, the
Netherlands.
(2)Department of Laboratory Medicine, Haematology, Ghent University Hospital,
Ghent, Belgium.
(3)Department of Paediatric Oncology/Haematology, VU University Medical Center,
Amsterdam, the Netherlands.
(4)Princess Máxima Center for Paediatric Oncology, Utrecht, the Netherlands.
(5)Department of Immunology, Erasmus MC, University Medical Center Rotterdam,
Rotterdam, the Netherlands.
(6)Dutch Childhood Oncology Group, The Hague, the Netherlands.
(7)Department of Paediatric Haematology-Oncology and Stem Cell Transplantation,
Ghent University Hospital, Ghent, Belgium.
(8)Cancer Research Institute Ghent, Ghent, Belgium.
(9)Department of Paediatric Oncology/Haematology, Beatrix Children's Hospital,
University Medical Center Groningen, University of Groningen, Groningen, the
Netherlands.
(10)Department of Paediatric Oncology/Haematology, Erasmus MC, University Medical
Center Rotterdam, Rotterdam, the Netherlands.
(11)Department of Clinical Biology, Microbiology and Immunology, Ghent
University, Ghent, Belgium.

DOI: 10.1111/bjh.14991 
PMID: 29076143  [Indexed for MEDLINE]

